Genomic Health (NASDAQ: GHDX) reported Q3 EPS of ($0.08), $0.01 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $82.3 million versus the consensus estimate of $83.24 million.

For earnings history and earnings-related data on Genomic Health (GHDX) click here.